These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29084790)
21. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Chen JH; Ou HT; Lin TC; Lai EC; Kao YH Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503 [TBL] [Abstract][Full Text] [Related]
22. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750 [TBL] [Abstract][Full Text] [Related]
23. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study. Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402 [TBL] [Abstract][Full Text] [Related]
24. Impact of blinded retrospective continuous glucose monitoring on clinical decision making and glycemic control in persons with type 2 diabetes on insulin therapy. Ribeiro RT; Andrade R; Nascimento do Ó D; Lopes AF; Raposo JF Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1267-1275. PubMed ID: 33612381 [TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial. Ried-Larsen M; Christensen R; Hansen KB; Johansen MY; Pedersen M; Zacho M; Hansen LS; Kofoed K; Thomsen K; Jensen MS; Nielsen RO; MacDonald C; Langberg H; Vaag AA; Pedersen BK; Karstoft K BMJ Open; 2015 Dec; 5(12):e009764. PubMed ID: 26656025 [TBL] [Abstract][Full Text] [Related]
26. Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial. Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Khan NF; Lee M; Vachon A; Iliadis TL; Hollands W; Doheny S; Elman S; Kraft JM; Naseem S; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD Am Heart J; 2016 Oct; 180():90-7. PubMed ID: 27659887 [TBL] [Abstract][Full Text] [Related]
27. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital. Cani CG; Lopes Lda S; Queiroz M; Nery M Clinics (Sao Paulo); 2015 Feb; 70(2):102-6. PubMed ID: 25789518 [TBL] [Abstract][Full Text] [Related]
28. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. O'Connor PJ; Schmittdiel JA; Pathak RD; Harris RI; Newton KM; Ohnsorg KA; Heisler M; Sterrett AT; Xu S; Dyer WT; Raebel MA; Thomas A; Schroeder EB; Desai JR; Steiner JF Diabetes Care; 2014 Dec; 37(12):3317-24. PubMed ID: 25315207 [TBL] [Abstract][Full Text] [Related]
29. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial. Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495 [TBL] [Abstract][Full Text] [Related]
30. Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes. Garry EM; Schneeweiss S; Eapen S; Petruski-Ivleva N; Cheever E; Murk W; Rajan A; Rassen JA; Gambino D; Jang H; Rubin E; Jan S J Manag Care Spec Pharm; 2019 Dec; 25(12):1442-1452. PubMed ID: 31778623 [TBL] [Abstract][Full Text] [Related]
31. Implementation of blood glucose self-monitoring among insulin-dependent patients with type 2 diabetes in three rural districts in Rwanda: 6 months open randomised controlled trial. Ng'ang'a L; Ngoga G; Dusabeyezu S; Hedt-Gauthier BL; Ngamije P; Habiyaremye M; Harerimana E; Ndayisaba G; Rusangwa C; Niyonsenga SP; Bavuma CM; Bukhman G; Adler AJ; Kateera F; Park PH BMJ Open; 2020 Jul; 10(7):e036202. PubMed ID: 32718924 [TBL] [Abstract][Full Text] [Related]
32. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. Pousinho S; Morgado M; Falcão A; Alves G J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912 [TBL] [Abstract][Full Text] [Related]
33. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial. Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256 [TBL] [Abstract][Full Text] [Related]
35. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home. Prudencio J; Cutler T; Roberts S; Marin S; Wilson M J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290 [TBL] [Abstract][Full Text] [Related]
36. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Buysman EK; Liu F; Hammer M; Langer J Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470 [TBL] [Abstract][Full Text] [Related]
37. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715 [TBL] [Abstract][Full Text] [Related]
38. Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol. Furler JS; Young D; Best J; Patterson E; O'Neal D; Liew D; Speight J; Segal L; May C; Manski-Nankervis JA; Holmes-Truscott E; Ginnivan L; Blackberry ID Implement Sci; 2014 Feb; 9():20. PubMed ID: 24528528 [TBL] [Abstract][Full Text] [Related]
39. Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial. Karagiannis T; Liakos A; Branda ME; Athanasiadou E; Mainou M; Boura P; Goulis DG; LeBlanc A; Montori VM; Tsapas A BMJ Open; 2016 Nov; 6(11):e012185. PubMed ID: 28186933 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease. Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]